Dominari Holdings Inc.
DOMH
Price:
$1.6894
Market Cap:
$10.60M
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimor...[Read more]
Industry
Biotechnology
IPO Date
1980-03-18
Stock Exchange
NASDAQ
Ticker
DOMH
PE Ratio
[-0.44]
ROE
[-43.75%]
Current Ratio
[7.38]
Dividend Yield
[0%]
Enterprise Value
[8.04M]
Dividend History
The ROE as of November 2024 (TTM) for Dominari Holdings Inc. (DOMH) is -43.75%
According to Dominari Holdings Inc.’s latest financial reports and current stock price. The company's current ROE is -43.75%. This represents a change of 288.92% compared to the average of -11.25% of the last 4 quarters.
Dominari Holdings Inc. (DOMH) Historical ROE (quarterly & annually)
How has DOMH ROE performed in the past?
The mean historical ROE of Dominari Holdings Inc. over the last ten years is -101.69%. The current -43.75% ROE has changed -56.97% with respect to the historical average. Over the past ten years (40 quarters), DOMH's ROE was at its highest in in the December 2018 quarter at 45.48%. The ROE was at its lowest in in the June 2015 quarter at -433.14%.
Average
-101.69%
Median
-47.76%
Minimum
-588.17%
Maximum
14.28%
Dominari Holdings Inc. (DOMH) ROE by Quarter and Year
Discovering the peaks and valleys of Dominari Holdings Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 932.29%
Maximum Annual ROE = 14.28%
Minimum Annual Increase = -378.23%
Minimum Annual ROE = -588.17%
| Year | ROE | Change |
|---|---|---|
| 2023 | -43.24% | -17.30% |
| 2022 | -52.28% | 667.70% |
| 2021 | -6.81% | -83.65% |
| 2020 | -41.65% | 4.88% |
| 2019 | -39.72% | -378.23% |
| 2018 | 14.28% | -117.73% |
| 2017 | -80.52% | -33.88% |
| 2016 | -121.78% | -79.30% |
| 2015 | -588.17% | 932.29% |
| 2014 | -56.98% | 53.19% |
Dominari Holdings Inc. (DOMH) Average ROE
How has DOMH ROE performed in the past?
The current ROE of Dominari Holdings Inc. (DOMH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-34.11%
5-year avg
-36.74%
10-year avg
-101.69%
Dominari Holdings Inc. (DOMH) ROE vs. Peers
How is DOMH’s ROE compared to its peers?
Dominari Holdings Inc.’s ROE is greater than CytomX Therapeutics, Inc. (-27.44%), greater than Instil Bio, Inc. (-55.57%), greater than Neoleukin Therapeutics, Inc. (-47.64%), less than Spero Therapeutics, Inc. (20.70%), greater than Assembly Biosciences, Inc. (-121.55%), greater than Achilles Therapeutics plc (-47.36%), greater than NextCure, Inc. (-57.63%), greater than Senti Biosciences, Inc. (-91.09%), greater than Hillstream BioPharma, Inc. (-47249.59%), greater than SAB Biotherapeutics, Inc. (-94.04%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Bolt Biotherapeutics, Inc. (-61.40%), greater than Pasithea Therapeutics Corp. (-74.63%), greater than MediciNova, Inc. (-13.37%), greater than Fresh Tracks Therapeutics, Inc. (-14.73%),
| Company | ROE | Market cap |
|---|---|---|
| -27.44% | $78.90M | |
| -55.57% | $179.70M | |
| -47.64% | $8.20M | |
| 20.70% | $69.72M | |
| -121.55% | $107.75M | |
| -47.36% | $42.12M | |
| -57.63% | $36.65M | |
| -91.09% | $10.26M | |
| -47249.59% | $4.17M | |
| -94.04% | $37.29M | |
| -112.11% | $2.86M | |
| -61.40% | $25.56M | |
| -74.63% | $3.78M | |
| -13.37% | $82.40M | |
| -14.73% | $4.42M |
Build a custom stock screener for Dominari Holdings Inc. (DOMH) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dominari Holdings Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Dominari Holdings Inc. (DOMH) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Dominari Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Dominari Holdings Inc.'s ROE?
How is the ROE calculated for Dominari Holdings Inc. (DOMH)?
What is the highest ROE for Dominari Holdings Inc. (DOMH)?
What is the 3-year average ROE for Dominari Holdings Inc. (DOMH)?
What is the 5-year average ROE for Dominari Holdings Inc. (DOMH)?
How does the current ROE for Dominari Holdings Inc. (DOMH) compare to its historical average?